Tulane University researchers are developing a vaccine formulation that may provide longer lasting immunity in fewer doses against pertussis, more commonly known as “whooping cough.” Microbiologist Lisa Morici, PhD, and immunologist James McLachlan, PhD, [Read more]
The National Institutes of Health (NIH) has selected Soligenix’s SGX942 (dusquetide) for the treatment of oral mucositis in head and neck cancer (HNC) patients as a Small Business Innovation Research/Small Business Technology [Read more]
Spero Therapeutics, Inc. today announced that it was awarded funding of $15.7 million, with the potential for up to an additional $28.5 million over 5 years, from the Biomedical Advanced Research and Development Authority (BARDA). The funding [Read more]
The mission of the Cooperative Threat Reduction (CTR) program is to partner with willing countries to reduce threat from weapons of mass destruction (WMD) and related materials, technologies, facilities, and expertise. The [Read more]
The U.S. Navy is awarding funding to the Noguchi Memorial Institute for Medical Research in Ghana in support of infectious disease research in Western Africa. The contract is on behalf of the U.S. [Read more]
Humanetics Corporation has been awarded a three-year contract valued at approximately $5.4 million from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The contract [Read more]
The National Institute of Allergy and Infectious Diseases (NIAID) Integrated Research Facility (IRF) is part of the National Interagency Biodefense Campus based at Fort Detrick, Maryland. Under a new contract worth up [Read more]
Cherokee Nation Technologies LLC, a native tribe, doing business as CNT, Catoosa, Oklahoma, is being awarded a $55,067,430 firm-fixed-price order, HT0011-18-F-0022. This order provides services to assist the Assistant Secretary of Defense [Read more]
AbCellera Biologics Inc. this week announced that it was awarded a contract from the Defense Advanced Research Projects Agency (DARPA) to develop rapid countermeasures against viral outbreaks. Under DARPA’s Pandemic Prevention Platform (P3) [Read more]
Researchers at Texas Biomedical Research Institute in San Antonio have been awarded a $2 million dollar contract by the makers of ZMapp, Mapp Biopharmaceutical, Inc., to further test this promising new therapeutic [Read more]
© 2018 STEMAR MEDIA